Cargando…

Case Report: Roxadustat in Combination With Rituximab Was Used to Treat EPO-Induced Pure Red Cell Aplasia

Recombinant human erythropoietin (rHuEPO) is a drug given to patients who have low hemoglobin related to chronic kidney disease or other anemia-related diseases. Some patients who receive rHuEPO repeatedly develop anti-rHuEPO-neutralizing antibodies, leading to the occurrence of pure red cell aplasi...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, Xiaoe, Guo, Baochun, Wang, Zhen, Ma, Hualin, Zhou, Ru, Liu, Lixia, Zhang, Xinzhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Nephrology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479623/ https://www.ncbi.nlm.nih.gov/pubmed/37675011 http://dx.doi.org/10.3389/fneph.2022.847847

Ejemplares similares

Label-free quantitative proteomic analysis of serum exosomes from patients of renal anemia: The Good and the Bad of Roxadustat
por: You, Xiaoe, et al.
Publicado: (2022)

Resolution of epoetin‐induced pure red cell aplasia, successful re‐challenge with roxadustat
por: Wu, Yunzhou, et al.
Publicado: (2020)

Roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia
por: Xu, Bojun, et al.
Publicado: (2021)

Safety and Effectiveness of Roxadustat in Dialysis-Dependent Patients With Renal Anemia: A Hospital-Based Cohort Study
por: Moussa, Oumarou, et al.
Publicado: (2022)

Rituximab: A viable treatment option for epoetin-induced pure red cell aplasia
por: Mahajan, S. A., et al.
Publicado: (2015)

Case Report: Immune checkpoint inhibitor–induced multiorgan vasculitis successfully treated with rituximab
por: Qureshi, Sehrish, et al.
Publicado: (2023)

Primary acquired chronic pure red cell aplasia refractory to standard treatments: remission with rituximab
por: Tendas, Andrea, et al.
Publicado: (2016)

Myelodysplastic Syndrome with Erythroid Aplasia following Pure Red Cell Aplasia
por: Kim, Hyoung Doo, et al.
Publicado: (2004)

Secondary pure red cell aplasia in multiple myeloma treated with lenalidomide
por: Ito, Tomoki, et al.
Publicado: (2018)

Pure red cell aplasia and associated thymoma
por: Rosu, Cristian, et al.
Publicado: (2011)

Lenalidomide-Induced Pure Red Cell Aplasia
por: Dolai, Tuphan Kanti, et al.
Publicado: (2014)

Emtricitabine-induced pure red cell aplasia
por: Manickchund, Nithendra, et al.
Publicado: (2019)

Erythropoietin‐induced pure red cell aplasia
por: Yeung, Vivian K. P.
Publicado: (2022)

Pure Red Cell Aplasia Associated With Thymoma
por: Thangatorai, Ramesh
Publicado: (2023)

TKI-induced pure red cell aplasia: first case report of pure red cell aplasia with both imatinib and nilotinib
por: Poudyal, Bishesh Sharma, et al.
Publicado: (2016)

Pembrolizumab-induced Pure Red Cell Aplasia Successfully Treated with Intravenous Immunoglobulin
por: Isoda, Atsushi, et al.
Publicado: (2020)

Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With Cyclosporin
por: Watanabe, Kageaki, et al.
Publicado: (2020)

Pure Red Blood Cell Aplasia and Isoniazid Use
por: Loulergue, Pierre, et al.
Publicado: (2007)

Zidovudine-induced reversible pure red cell aplasia
por: Balakrishnan, Anuja, et al.
Publicado: (2010)

Thymoma associated with hypogammaglobulinaemia and pure red cell aplasia
por: Briones, Juan, et al.
Publicado: (2013)

Rational management approach to pure red cell aplasia
por: Balasubramanian, Suresh Kumar, et al.
Publicado: (2018)

Pure red cell aplasia induced by epoetin zeta
por: Panichi, Vincenzo, et al.
Publicado: (2016)

Pure Red Cell Aplasia Associated with Good Syndrome
por: Okui, Masayuki, et al.
Publicado: (2017)

Isoniazid Induced Pure Red Blood Cell Aplasia
por: Azhar, Waqas, et al.
Publicado: (2020)

Acquired Pure Red Cell Aplasia and Recombinant Erythropoietin
por: Padhi, Somanath, et al.
Publicado: (2021)

Clonal hematopoiesis in adult pure red cell aplasia
por: Fujishima, Naohito, et al.
Publicado: (2021)

Rituximab therapy for pure red cell aplasia due to anti-epoetin antibodies in a woman treated with epoetin-alfa: a case report
por: Behler, Caroline M, et al.
Publicado: (2009)

Del(5q) myelodysplastic syndrome combined with pure red cell aplasia
por: Park, Joowon
Publicado: (2018)

Pure red cell aplasia associated with autoimmune hepatitis successfully treated with cyclosporine A
por: Sato, Akira, et al.
Publicado: (2014)

Pure red cell aplasia accompanied by COVID-19 successfully treated using cyclosporine
por: Yamazaki, Susumu, et al.
Publicado: (2022)

Effect of Roxadustat versus erythropoietin (EPO) for treating anemia in patients with diabetic kidney disease: a retrospective cohort study
por: Zhang, Lei, et al.
Publicado: (2022)

Acquired pure red cell aplasia: updated review of treatment
por: Sawada, Kenichi, et al.
Publicado: (2008)

Pure Red Cell Aplasia and Lymphoproliferative Disorders: An Infrequent Association
por: Vlachaki, Efthymia, et al.
Publicado: (2012)

Pure Red Cell Aplasia Caused by Acute Hepatitis A
por: Lee, Tae Heon, et al.
Publicado: (2011)

Pure Red Cell Aplasia Following Interleukin-2 Therapy
por: Dutcher, Janice P., et al.
Publicado: (2016)

Pure Red Cell Aplasia with Adult Onset Still's Disease
por: Robillard, Nicholas, et al.
Publicado: (2013)

Invasive Thymoma with Pure Red Cell Aplasia and Amegakaryocytic Thrombocytopenia
por: Onuki, Takuya, et al.
Publicado: (2016)

Acquired Amegakaryocytic Thrombocytopenia and Pure Red Cell Aplasia in Thymoma
por: Dahal, Sumit, et al.
Publicado: (2018)

Aggressive Systemic Mastocytosis in Association with Pure Red Cell Aplasia
por: Karam, Dhauna, et al.
Publicado: (2018)

Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation
por: Jung, Sung-Hoon, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_u1d308i34fe38477emceeu4929